Li Haifeng, Sun Wei, Fu Shengfeng, Wang Junfeng, Jin Bin, Zhang Shuo, Liu Yujun, Zhang Qinyang, Wang Honggang
Department of General Surgery, Taizhou School of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, 366 Taihu Road, Taizhou, China.
Postgraduate School, Dalian Medical University, Dalian, China.
BMC Cancer. 2025 Mar 5;25(1):403. doi: 10.1186/s12885-025-13828-3.
Colorectal cancer (CRC) is a common malignant tumor of the digestive tract. Although many prognostic indicators are currently available, it remains unclear which indicators are the most beneficial for patients with CRC. Therefore, there is a critical need to identify a simple, convenient and accurate prognostic indicator.
To investigate the clinical significance of the systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) as prognostic indicators for the survival of patients with CRC.
The clinical data of CRC patients admitted to the general surgery ward of Taizhou People's Hospital affiliated to Nanjing Medical University from January 2015 to January 2018 were retrospectively analyzed. Two prognostic indicators (SII and PNI) were compared to evaluate their prognostic value in CRC patients.
Based on these variables, we constructed a LASSO prediction model. The AUC (Area Under the Curve) value and 95% CI of the training group were 0.917 (0.858-0.976) compared to 0.932 (0.846-1.000) in the validation group. We found that CEA > 5 ng/mL, tumor stage, pathological type, postoperative complications, and PNI were associated with the five-year survival rate of CRC patients. Receiver Operating Characteristic Curves (ROC) were drawn to assess the prediction accuracy of the model. The AUC and 95% CI of the training group were 0.913 (0.854-0.972), while the AUC and 95% CI of the validation group were 0.954 (0.899-1.000).
PNI is an independent risk factor for postoperative complications associated with CRC and a powerful tool for predicting survival outcomes in CRC patients.
结直肠癌(CRC)是常见的消化道恶性肿瘤。尽管目前有许多预后指标,但尚不清楚哪些指标对CRC患者最为有益。因此,迫切需要确定一个简单、便捷且准确的预后指标。
探讨全身免疫炎症指数(SII)和预后营养指数(PNI)作为CRC患者生存预后指标的临床意义。
回顾性分析2015年1月至2018年1月在南京医科大学附属泰州人民医院普通外科病房收治的CRC患者的临床资料。比较两个预后指标(SII和PNI)以评估它们在CRC患者中的预后价值。
基于这些变量,我们构建了一个LASSO预测模型。训练组的曲线下面积(AUC)值和95%置信区间为0.917(0.858 - 0.976),而验证组为0.932(0.846 - 1.000)。我们发现癌胚抗原(CEA)> 5 ng/mL、肿瘤分期、病理类型、术后并发症和PNI与CRC患者的五年生存率相关。绘制受试者工作特征曲线(ROC)以评估模型的预测准确性。训练组的AUC和95%置信区间为0.913(0.854 - 0.972),而验证组的AUC和95%置信区间为0.954(0.899 - 1.000)。
PNI是CRC术后并发症的独立危险因素,也是预测CRC患者生存结局的有力工具。